Sort   by:  
 Page size 
UnknownGenetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Not available
S-EPMC5834058 | biostudies-literature
UnknownWhat do cancer patients experience of the simultaneous care clinic? Results of a cross-sectional study on patient care satisfaction.
Not available
S-EPMC10891442 | biostudies-literature
UnknownSingle Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE Trial.
Not available
S-EPMC7408001 | biostudies-literature
UnknownAssociation of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas.
Not available
S-EPMC8624955 | biostudies-literature
UnknownPattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
Not available
S-EPMC10356632 | biostudies-literature
UnknownUpfront Modified FOLFOXIRI Plus Panitumumab for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study.
Not available
S-EPMC12879191 | biostudies-literature
UnknownImpact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial.
Not available
S-EPMC12221353 | biostudies-literature
UnknownUpfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO.
Not available
S-EPMC9426812 | biostudies-literature
UnknownTemozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
Not available
S-EPMC9084437 | biostudies-literature
Sort   by:  
 Page size